Photodynamic therapy—current limitations and novel approaches G Gunaydin, ME Gedik, S Ayan Frontiers in Chemistry 9, 691697, 2021 | 440 | 2021 |
Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status G Gunaydin, ME Gedik, S Ayan Frontiers in chemistry 9, 686303, 2021 | 339 | 2021 |
Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs B Gok Yavuz, G Gunaydin, ME Gedik, K Kosemehmetoglu, D Karakoc, ... Scientific reports 9 (1), 3172, 2019 | 267 | 2019 |
Proof-of-principle for two-stage photodynamic therapy: hypoxia triggered release of singlet oxygen S Ayan, G Gunaydin, N Yesilgul-Mehmetcik, ME Gedik, O Seven, ... Chemical Communications 56 (94), 14793-14796, 2020 | 50 | 2020 |
Amphiphilic Fullerene‐BODIPY Photosensitizers for Targeted Photodynamic Therapy EÖ Gündüz, ME Gedik, G Günaydın, E Okutan ChemMedChem 17 (6), e202100693, 2022 | 30 | 2022 |
Development of carboplatin loaded bovine serum albumin nanoparticles and evaluation of its effect on an ovarian cancer cell line O Esim, ME Gedik, AL Dogan, G Gunaydin, C Hascicek Journal of Drug Delivery Science and Technology 64, 102655, 2021 | 23 | 2021 |
BODIPY–GO nanocomposites decorated with a biocompatible branched ethylene glycol moiety for targeted PDT EÖ Gündüz, R Atajanov, ME Gedik, ET Eçik, G Günaydın, E Okutan Dalton Transactions 52 (17), 5466-5477, 2023 | 10 | 2023 |
Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer O Saatci, R Alam, KT Huynh-Dam, A Isik, M Uner, N Belder, PG Ersan, ... Cell Death & Disease 15 (6), 418, 2024 | 9 | 2024 |
NI-Bodipy-GO nanocomposites for targeted PDT E Öztürk Gündüz, B Tasasız, ME Gedik, G Günaydın, E Okutan ACS omega 8 (9), 8320-8331, 2023 | 8 | 2023 |
Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer ME Gedik, O Saatci, N Oberholtzer, M Uner, O Akbulut Caliskan, M Cetin, ... Cancer research 84 (9), 1475-1490, 2024 | 6 | 2024 |
Can endocan serve as a molecular “hepatostat” in liver regeneration? SE Yazici, ME Gedik, CB Leblebici, K Kosemehmetoglu, G Gunaydin, ... Molecular Medicine 29 (1), 29, 2023 | 6 | 2023 |
Effects of cellular energy homeostasis modulation through AMPK on regulation of protein translation and response to hypoxia G Gunaydin, ME Gedik Turkish Journal of Biochemistry 44 (5), 611-620, 2019 | 6 | 2019 |
Carboplatin and decitabine loaded lipid-coated albumin nanoparticles for an efficient treatment of platinum-resistant ovarian cancer O Esim, C Hascicek, ME Gedik, G Gunaydin, AL Dogan Journal of Drug Delivery Science and Technology 76, 103801, 2022 | 5 | 2022 |
Candidate Angiogenesis‐Related Biomarkers in Patients with Laryngeal Carcinoma (AngLaC): A Prospective Cohort Study AE Pamuk, ME Gedik, N Sutay Suslu, G Gunaydin Otolaryngology–Head and Neck Surgery 168 (6), 1433-1442, 2023 | 3 | 2023 |
Cover Feature: Amphiphilic Fullerene‐BODIPY Photosensitizers for Targeted Photodynamic Therapy (ChemMedChem 6/2022) EÖ Gündüz, ME Gedik, G Günaydın, E Okutan ChemMedChem 17 (6), e202200117, 2022 | 3 | 2022 |
Radiosensitising effects of metformin added to concomitant chemoradiotherapy with cisplatin in cervical cancer CSB Esen, ME Gedik, H Canpinar, FY Yedekci, F Yildiz, G Gunaydin, ... Clinical Oncology 35 (11), 744-755, 2023 | 2 | 2023 |
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer ME Gedik, O Saatci, N Oberholtzer, M Uner, O Akbulut, M Cetin, M Aras, ... bioRxiv, 2023 | 2 | 2023 |
MEME KANSERİ VE HEPATOSELLÜLER KANSER HÜCRE DİZİLERİNDE AMPK MODÜLASYONUNUN KANSER HÜCRE PROLİFERASYONU ÜZERİNE ETKİSİNİN GERÇEK-ZAMANLI HÜCRE ANALİZ SİSTEMİ xCELLigence … G Günaydın, ME Gedik Bozok Tıp Dergisi 8 (4), 95-103, 2018 | 2 | 2018 |
Modulation of AMPK significantly alters uveal melanoma tumor cell viability O Deliktas, ME Gedik, I Koc, G Gunaydin, H Kiratli Ophthalmic Research 66 (1), 1230-1244, 2023 | 1 | 2023 |
BODIPY-GO nanocomposites decorated with a biocompatible branched ethylene glycol moiety for targeted PDT. R Atajanov, ME Gedik, G Günaydın, E Okutan Dalton Transactions (Cambridge, England: 2003), 2023 | 1 | 2023 |